| Ident. | Authors (with country if any) | Title |
|---|
| 000041 |
Tulio De Oliveira [Afrique du Sud] ; Ayesha B M. Kharsany [Afrique du Sud] ; Tiago Gr F [Afrique du Sud] ; Cherie Cawood [Afrique du Sud] ; David Khanyile [Afrique du Sud] ; Anneke Grobler [Afrique du Sud] ; Adrian Puren [Afrique du Sud] ; Savathree Madurai [Afrique du Sud] ; Cheryl Baxter [Afrique du Sud] ; Quarraisha Abdool Karim [États-Unis] ; Salim S Abdool Karim [États-Unis] | Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. |
| 000045 |
Carolyn M. Audet [États-Unis] ; Sizzy Ngobeni [Afrique du Sud] ; Ryan G. Wagner [Afrique du Sud] | Traditional healer treatment of HIV persists in the era of ART: a mixed methods study from rural South Africa. |
| 000100 |
Constantinos Kurt Wibmer [Afrique du Sud] ; Jason Gorman [États-Unis] ; Gabriel Ozorowski [États-Unis] ; Jinal N. Bhiman [Afrique du Sud] ; Daniel J. Sheward [Afrique du Sud] ; Debra H. Elliott [États-Unis] ; Julie Rouelle [États-Unis] ; Ashley Smira [États-Unis] ; M Gordon Joyce [États-Unis] ; Nonkululeko Ndabambi [Afrique du Sud] ; Aliaksandr Druz [États-Unis] ; Mangai Asokan [États-Unis] ; Dennis R. Burton [États-Unis] ; Mark Connors [États-Unis] ; Salim S. Abdool Karim [Afrique du Sud] ; John R. Mascola [États-Unis] ; James E. Robinson [États-Unis] ; Andrew B. Ward [États-Unis] ; Carolyn Williamson [Afrique du Sud] ; Peter D. Kwong [États-Unis] ; Lynn Morris [Afrique du Sud] ; Penny L. Moore [Afrique du Sud] | Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. |
| 000116 |
Jinal N. Bhiman [Afrique du Sud] ; Penny L. Moore [Afrique du Sud] | Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex Defenses. |
| 000149 |
Maria Paximadis [Afrique du Sud] ; Refilwe N. Ngqobe [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Neil A. Martinson [Afrique du Sud] ; Caroline T. Tiemessen [Afrique du Sud] | RICH2 is implicated in viraemic control of HIV-1 in black South African individuals. |
| 000204 |
Penny L. Moore [Afrique du Sud] ; Jason Gorman [États-Unis] ; Nicole A. Doria-Rose [États-Unis] ; Lynn Morris [Afrique du Sud] | Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies. |
| 000254 |
Awoke Seyoum [Éthiopie] ; Principal Ndlovu [Afrique du Sud] ; Zewotir Temesgen [Afrique du Sud] | Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region). |
| 000343 |
Faatima Laher [Afrique du Sud] ; Srinika Ranasinghe [États-Unis] ; Filippos Porichis [États-Unis] ; Nikoshia Mewalal [Afrique du Sud] ; Karyn Pretorius [Afrique du Sud] ; Nasreen Ismail [Afrique du Sud] ; S Ren Buus [Danemark] ; Anette Stryhn [Danemark] ; Mary Carrington [États-Unis] ; Bruce D. Walker [Afrique du Sud] ; Thumbi Ndung'U [Afrique du Sud] ; Zaza M. Ndhlovu [États-Unis] | HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer(+) Gag-Specific CD4(+) T Cells in Chronic Clade C HIV-1 Infection. |
| 000378 |
Naseem Cassim [Afrique du Sud] ; Kathryn Schnippel [Afrique du Sud] ; Lindi Marie Coetzee [Afrique du Sud] ; Deborah Kim Glencross [Afrique du Sud] | Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa. |
| 000390 |
Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark] | Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. |
| 000392 |
Ramla F. Tanko [Afrique du Sud] ; Andreia P. Soares [Afrique du Sud] ; Tracey L. Müller [Afrique du Sud] ; Nigel J. Garrett [Afrique du Sud] ; Natasha Samsunder [Afrique du Sud] ; Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim [Afrique du Sud] ; Catherine Riou [Afrique du Sud] ; Wendy A. Burgers [Afrique du Sud] | Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women. |
| 000425 |
Allison L. Agwu [États-Unis] ; Meredith G. Warshaw [États-Unis] ; Elizabeth J. Mcfarland [États-Unis] ; George K. Siberry [États-Unis] ; Ann J. Melvin [États-Unis] ; Andrew A. Wiznia [États-Unis] ; Lee Fairlie [Afrique du Sud] ; Sandra Boyd [États-Unis] ; Paul Harding [États-Unis] ; Hans M L. Spiegel [États-Unis] ; Elaine J. Abrams [États-Unis] ; Vincent J. Carey [États-Unis] | Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. |
| 000441 |
Cristin Q. Fritz [États-Unis] ; Meridith Blevins [États-Unis] ; Mary Lou Lindegren [États-Unis] ; Kara Wools-Kaloutsian [États-Unis] ; Beverly S. Musick [États-Unis] ; Morna Cornell [Afrique du Sud] ; Kelly Goodwin [Suisse] ; Dianne Addison [États-Unis] ; Jean Claude Dusingize [Rwanda] ; Eugène Messou [Côte d'Ivoire] ; Armel Poda [Burkina Faso] ; Stephany N. Duda [États-Unis] ; Catherine C. Mcgowan [États-Unis] ; Matthew G. Law [Australie] ; Richard D. Moore [États-Unis] ; Aimee Freeman [États-Unis] ; Denis Nash [États-Unis] ; C William Wester [États-Unis] | Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. |
| 000456 |
Reneé De Waal [Afrique du Sud] ; Karen Cohen [Afrique du Sud] ; Matthew P. Fox [États-Unis] ; Kathryn Stinson [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Andrew Boulle [Afrique du Sud] ; Ehimario U. Igumbor [Afrique du Sud] ; Mary-Ann Davies [Afrique du Sud] | Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study. |
| 000474 |
Jinal N. Bhiman [Afrique du Sud] ; Rebecca M. Lynch [États-Unis] | Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System. |
| 000497 |
Lindi Marie Coetzee [Afrique du Sud] ; Naseem Cassim ; Deborah Kim Glencross | Analysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support. |
| 000819 |
Naadira Vanker [Afrique du Sud] ; Hayley Ipp | Large unstained cells: a potentially valuable parameter in the assessment of immune activation levels in HIV infection. |
| 000823 |
Geoffrey Fatti [Afrique du Sud] ; Najma Shaikh ; Brian Eley ; Ashraf Grimwood | Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa. |
| 000872 |
Max R. O Donnell [Afrique du Sud] ; Allison Wolf ; Lise Werner ; C Robert Horsburgh ; Nesri Padayatchi | Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study. |
| 000895 |
Gilles Wandeler [Afrique du Sud] ; Thomas Gsponer ; Lloyd Mulenga ; Daniela Garone ; Robin Wood ; Mhairi Maskew ; Hans Prozesky ; Christopher Hoffmann ; Jochen Ehmer ; Diana Dickinson ; Mary-Ann Davies ; Matthias Egger ; Olivia Keiser | Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa. |
| 000899 |
Kogieleum Naidoo [Afrique du Sud] ; Cheryl Baxter ; Salim S. Abdool Karim | When to start antiretroviral therapy during tuberculosis treatment? |
| 000908 |
Mhairi Maskew [Afrique du Sud] ; Matthew P. Fox ; Gilles Van Cutsem ; Kathryn Chu ; Patrick Macphail ; Andrew Boulle ; Matthias Egger ; For Iedea Southern Africa | Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. |
| 000912 |
Naadira Vanker [Afrique du Sud] ; Hayley Ipp | The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection. |
| 000923 |
Hayley Ipp [Afrique du Sud] ; Annalise Zemlin | The paradox of the immune response in HIV infection: when inflammation becomes harmful. |
| 000939 |
Aurelia Williams [Afrique du Sud] ; Francois Steffens ; Carolus Reinecke ; Debra Meyer | The Th1/Th2/Th17 cytokine profile of HIV-infected individuals: a multivariate cytokinomics approach. |
| 000942 |
Ankur Gupta-Wright [Afrique du Sud] ; Robin Wood ; Linda-Gail Bekker ; Stephen D. Lawn | Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service. |
| 000950 |
Jean Pierre Kabue [Afrique du Sud] ; Dalene De Swardt ; Corena De Beer ; Richard H. Glashoff | Short-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis. |
| 000963 |
Gerald K. Chege [Afrique du Sud] ; Wendy A. Burgers ; Helen Stutz ; Ann E. Meyers ; Rosamund Chapman ; Agano Kiravu ; Rubina Bunjun ; Enid G. Shephard ; William R. Jacobs ; Edward P. Rybicki ; Anna-Lise Williamson | Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model. |
| 000973 |
Melissa-Rose Abrahams [Afrique du Sud] ; Florette K. Treurnicht ; Nobubelo K. Ngandu ; Sarah A. Goodier ; Jinny C. Marais ; Helba Bredell ; Ruwayhida Thebus ; Debra De Assis Rosa ; Koleka Mlisana ; Cathal Seoighe ; Salim Abdool Karim ; Clive M. Gray ; Carolyn Williamson | Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression. |
| 000989 |
Werner Smidt [Afrique du Sud] | Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M. |
| 000A08 |
Vivek Naranbhai [Afrique du Sud] ; Natasha Samsunder ; Netanya G. Sandler ; Annalys Roque ; Quarraisha Abdool Karim ; Thumbi Ndung U ; William H. Carr ; Marcus Altfeld ; Daniel C. Douek ; Salim S. Abdool Karim | Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004. |
| 000A32 |
Sugeshnee Pather [Afrique du Sud] ; Zainab Mohamed ; Heather Mcleod ; Komala Pillay | Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping. |
| 000A37 |
V M S. Kalumba [Afrique du Sud] ; J. Moodley ; T D Naidoo | Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case-control study. |
| 000A38 |
Katherine M. Young [Afrique du Sud] ; Clive M. Gray [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] | Is obesity a risk factor for vaccine non-responsiveness? |
| 000A46 |
Kate Clouse [Afrique du Sud] ; Audrey Pettifor ; Mhairi Maskew ; Jean Bassett ; Annelies Van Rie ; Cynthia Gay ; Frieda Behets ; Ian Sanne ; Matthew P. Fox | Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. |
| 000A54 |
Michael Schomaker [Afrique du Sud] ; Matthias Egger ; Mhairi Maskew ; Daniela Garone ; Hans Prozesky ; Christopher J. Hoffmann ; Andrew Boulle ; Lukas Fenner | Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa. |
| 000A66 |
Jeffrey W. Eaton [Royaume-Uni] ; Nicolas A. Menzies [États-Unis] ; John Stover [États-Unis] ; Valentina Cambiano [Royaume-Uni] ; Leonid Chindelevitch [États-Unis] ; Anne Cori [Royaume-Uni] ; Jan A C. Hontelez [Pays-Bas] ; Salal Humair [États-Unis] ; Cliff C. Kerr [Australie] ; Daniel J. Klein [États-Unis] ; Sharmistha Mishra [Canada] ; Kate M. Mitchell [Royaume-Uni] ; Brooke E. Nichols [Pays-Bas] ; Peter Vickerman [Royaume-Uni] ; Roel Bakker [Pays-Bas] ; Till B Rnighausen [États-Unis] ; Anna Bershteyn [États-Unis] ; David E. Bloom [États-Unis] ; Marie-Claude Boily [Royaume-Uni] ; Stewart T. Chang [États-Unis] ; Ted Cohen [États-Unis] ; Peter J. Dodd [Royaume-Uni] ; Christophe Fraser [Royaume-Uni] ; Chaitra Gopalappa [États-Unis] ; Jens Lundgren [Danemark] ; Natasha K. Martin [Royaume-Uni] ; Evelinn Mikkelsen [Pays-Bas] ; Elisa Mountain [Royaume-Uni] ; Quang D. Pham [Australie] ; Michael Pickles [Royaume-Uni] ; Andrew Phillips [Royaume-Uni] ; Lucy Platt [Royaume-Uni] ; Carel Pretorius [États-Unis] ; Holly J. Prudden [Royaume-Uni] ; Joshua A. Salomon [États-Unis] ; David A M C. Van De Vijver [Pays-Bas] ; Sake J. De Vlas [Pays-Bas] ; Bradley G. Wagner [États-Unis] ; Richard G. White [Royaume-Uni] ; David P. Wilson [Australie] ; Lei Zhang [Australie] ; John Blandford [États-Unis] ; Gesine Meyer-Rath [Afrique du Sud] ; Michelle Remme [Royaume-Uni] ; Paul Revill [Royaume-Uni] ; Nalinee Sangrujee [États-Unis] ; Fern Terris-Prestholt [Royaume-Uni] ; Meg Doherty [Suisse] ; Nathan Shaffer [Suisse] ; Philippa J. Easterbrook [Suisse] ; Gottfried Hirnschall [Suisse] ; Timothy B. Hallett [Royaume-Uni] | Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. |
| 000A70 |
Karl Peltzer [Afrique du Sud, Thaïlande] | HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: A longitudinal study |
| 000A97 |
Omphile E. Simani [Afrique du Sud] ; Peter V. Adrian ; Avy Violari ; Locadiah Kuwanda ; Kennedy Otwombe ; Marta C. Nunes ; Mark F. Cotton ; Shabir A. Madhi | Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. |
| 000B04 |
G E Gray [Afrique du Sud] ; B. Metch ; G. Churchyard ; K. Mlisana ; M. Nchabeleng ; M. Allen ; Z. Moodie ; J. Kublin ; L-G Bekker | Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? |
| 000B21 |
Landon Myer [Afrique du Sud] ; Kristen Daskilewicz ; James Mcintyre ; Linda-Gail Bekker | Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women. |
| 000B34 |
Vivek Naranbhai [Afrique du Sud] ; Marcus Altfeld ; Salim S Abdool Karim ; Thumbi Ndung'U ; Quarraisha Abdool Karim ; William H. Carr | Changes in Natural Killer cell activation and function during primary HIV-1 Infection. |
| 000D63 |
Karl Peltzer [Afrique du Sud] ; Shandir Ramlagan ; Mohamed Salim Khan ; Bernhard Gaede | The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study. |
| 000D78 |
Karl Peltzer [Afrique du Sud] ; Shandir Ramlagan | Perceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa. |
| 000D88 |
Marianne W. Mureithi [Afrique du Sud] ; Kristen Cohen ; Ramona Moodley ; Danielle Poole ; Zenele Mncube ; Anne Kasmar ; D Branch Moody ; Philip J R. Goulder ; Bruce D. Walker ; Marcus Altfeld ; Thumbi Ndung'U | Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection. |
| 000F12 |
Morna Cornell [Afrique du Sud] ; Anna Grimsrud ; Lara Fairall ; Matthew P. Fox ; Gilles Van Cutsem ; Janet Giddy ; Robin Wood ; Hans Prozesky ; Lerato Mohapi ; Claire Graber ; Matthias Egger ; Andrew Boulle ; Landon Myer | Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. |
| 000F35 |
A B M. Kharsany [Afrique du Sud] ; N. Hancock ; J A Frohlich ; H R Humphries ; S S Abdool Karim ; Q. Abdool Karim | Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa. |
| 000F41 |
Christopher J. Hoffmann [Afrique du Sud] ; Katherine L. Fielding ; Salome Charalambous ; Craig Innes ; Richard E. Chaisson ; Alison D. Grant ; Gavin J. Churchyard | Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa. |
| 000F55 |
Lindi Roberts [Afrique du Sud] ; Jo-Ann S. Passmore ; Carolyn Williamson ; Francesca Little ; Lisa M. Bebell ; Koleka Mlisana ; Wendy A. Burgers ; Francois Van Loggerenberg ; Gerhard Walzl ; Joel F. Djoba Siawaya ; Quarraisha Abdool Karim ; Salim S Abdool Karim | Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. |
| 000F57 |
Edana Cassol [Afrique du Sud] ; Susan Malfeld ; Phetole Mahasha ; Schalk Van Der Merwe ; Sharon Cassol ; Chris Seebregts ; Massimo Alfano ; Guido Poli ; Theresa Rossouw | Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. |
| 000F64 |
Helena Rabie [Afrique du Sud] ; Andrea Lomp ; Pierre Goussard ; Ettienne Nel ; Mark Cotton | Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child. |
| 000F66 |
Glenda Gray [Afrique du Sud] ; Susan Buchbinder ; Ann Duerr | Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. |
| 000F74 |
Caroline T. Tiemessen [Afrique du Sud] ; Sharon Shalekoff ; Stephen Meddows-Taylor ; Diana B. Schramm ; Maria A. Papathanasopoulos ; Glenda E. Gray ; Gayle G. Sherman ; Ashraf H. Coovadia ; Louise Kuhn | Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection. |
| 000F81 |
Karen Cohen [Afrique du Sud] ; Graeme Meintjes | Management of individuals requiring antiretroviral therapy and TB treatment. |
| 000F94 |
Geoffrey Fatti [Afrique du Sud] ; Peter Bock ; Ashraf Grimwood ; Brian Eley | Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. |
| 001033 |
Marianne W. Mureith [Afrique du Sud] ; J Judy Chang ; Jeffrey D. Lifson ; Thumbi Ndung'U ; Marcus Altfeld | Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands. |
| 001046 |
Shabir A. Madhi [Afrique du Sud] ; Peter Adrian ; Mark F. Cotton ; James A. Mcintyre ; Patrick Jean-Philippe ; Shawn Meadows ; Sharon Nachman ; Helena K Yhty ; Keith P. Klugman ; Avye Violari | Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. |
| 001048 |
Sydney Rosen [États-Unis, Afrique du Sud] ; Bruce Larson [États-Unis] ; Alana Brennan [États-Unis, Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Matthew Fox [États-Unis, Afrique du Sud] ; Constance Mongwenyana [Afrique du Sud] ; Mpefe Ketlhapile [Afrique du Sud] ; Ian Sanne [Afrique du Sud] | Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment |
| 001071 |
Hamakwa Mantina [Afrique du Sud] ; Tracey M. Wiggill ; Sergio Carmona ; Yvonne Perner ; Wendy S. Stevens | Characterization of Lymphomas in a high prevalence HIV setting. |
| 001075 |
Stephen D. Lawn ; Robin Wood [Afrique du Sud] ; Robert J. Wilkinson | Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection |
| 001077 |
Vinod B. Patel [Afrique du Sud] ; Ravesh Singh ; Cathy Connolly ; Yacoob Coovadia ; Abdool K C. Peer ; Priyashini Parag ; Victoria Kasprowicz ; Alimuddin Zumla ; Thumbi Ndung'U ; Keertan Dheda | Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. |
| 001102 |
Habtom H. Habte [Afrique du Sud] ; Corena De Beer ; Zoë E. Lotz ; Paul Roux ; Anwar S. Mall | Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts. |
| 001108 |
Kavidha Reddy [Afrique du Sud] ; Cheryl A. Winkler ; Lise Werner ; Koleka Mlisana ; Salim S. Abdool Karim ; Thumbi Ndung'U | APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. |
| 001111 |
Pholo Maenetje [Afrique du Sud] ; Catherine Riou ; Joseph P. Casazza ; David Ambrozak ; Brenna Hill ; Glenda Gray ; Richard A. Koup ; Guy De Bruyn ; Clive M. Gray | A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. |
| 001113 |
Heather J. Zar [Afrique du Sud] ; Lesley Workman ; Stanzi M. Le Roux ; Teresa Jennings ; Nomawethu Jele ; Hendrick Simon Schaaf ; Ann Barclay-Loggie ; Chris Mulligan ; David M. Le Roux ; Carl J. Lombard ; Mark F. Cotton | A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children. |
| 001116 |
Eftyhia Vardas [Afrique du Sud] ; Pontiano Kaleebu ; Linda-Gail Bekker ; Anwar Hoosen ; Elwyn Chomba ; Philip R. Johnson ; Pervin Anklesaria ; Josephine Birungi ; Burc Barin ; Mark Boaz ; Josephine Cox ; Jennifer Lehrman ; Gwynn Stevens ; Jill Gilmour ; Tony Tarragona ; Peter Hayes ; Sarah Lowenbein ; Eva Kizito ; Patricia Fast ; Alison E. Heald ; Claudia Schmidt | A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus. |
| 001898 |
Ingrid Eshun-Wilson [Afrique du Sud] ; Fiona Havers ; Jean B. Nachega ; Hans W. Prozesky ; Jantjie J. Taljaard ; Michele D. Zeier ; Mark Cotton ; Gary Simon ; Patrick Soentjens | Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings. |
